Emily Piccione
- Physiology top 2%
- Adenosine and Purinergic Signaling 4
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 3
- Phagocytosis and Immune Regulation 2
- Oncology top 10%
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Click Chemistry and Applications 2
- Co-authors
- Richard A. MillerJoseph J. BuggyAndrew HotsonSilvia JuárezSerena TsengRavindra MajetiCyndhavi NarayananLijuan Wang
- Cited by
- PhysiologyImmunologyOncology
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Emily Piccione
17 papers receiving 523 citations
Peers
Comparison fields: 5 of 43
- Physiology 124
- Immunology 278
- Oncology 307
- Pathology and Forensic Medicine 124
- Radiology, Nuclear Medicine and Imaging 107
Countries citing papers authored by Emily Piccione
This map shows the geographic impact of Emily Piccione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Piccione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Piccione more than expected).
Fields of papers citing papers by Emily Piccione
This network shows the impact of papers produced by Emily Piccione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Piccione. The network helps show where Emily Piccione may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Piccione, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 34 | |
| 3 | 2022 | 16 | |
| 4 | 2022 | 16 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 46 | |
| 11 | 2020 | 44 | |
| 12 | 2019 | 36 | |
| 13 | 2018 | 162 | |
| 14 | 2017 | 5 | |
| 15 | 2016 | 41 | |
| 16 | 2016 | 4 | |
| 17 | 2015 | 119 | |
| 18 | [Veralipride in the treatment of hot flushes in the menopause]. | 1985 | 1 |
About Emily Piccione
Emily Piccione is a scholar working on Physiology, Oncology and Pathology and Forensic Medicine, having authored 18 papers that have together received 537 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Adenosine and Purinergic Signaling (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Click Chemistry and Applications (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Physiology (124 citations), Immunology (278 citations) and Oncology (307 citations). Emily Piccione has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Richard A. Miller, Joseph J. Buggy, Andrew Hotson, Silvia Juárez, Serena Tseng, Ravindra Majeti, Cyndhavi Narayanan, Lijuan Wang, Kipp Weiskopf and Po Y. Ho. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.